According to Ionis Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$2.87. In 2022 the company made an earnings per share (EPS) of -$1.90 a decrease over its 2021 EPS that were of -$0.20.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.87 | 51.05% |
2022 | -$1.90 | 850% |
2021 | -$0.20 | -93.51% |
2020 | -$3.08 | -245.28% |
2019 | $2.12 | 6.53% |
2018 | $1.99 | 3880% |
2017 | $0.05000 | -106.94% |
2016 | -$0.72 | -1.37% |
2015 | -$0.73 | 114.71% |
2014 | -$0.34 | -35.85% |
2013 | -$0.53 | -18.46% |
2012 | -$0.65 | -23.53% |
2011 | -$0.85 | 37.1% |
2010 | -$0.62 | -138.99% |
2009 | $1.59 | -936.84% |
2008 | -$0.19 | -88.13% |
2007 | -$1.60 | 162.3% |
2006 | -$0.61 | -47.86% |
2005 | -$1.17 | -53.57% |
2004 | -$2.52 | 46.51% |
2003 | -$1.72 | 27.41% |
2002 | -$1.35 | -21.51% |
2001 | -$1.72 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -$0.06000 | -97.91% | Bahamas |
NRC Health
NRC | $1.19 | -141.46% | ๐บ๐ธ USA |